InsidersTradesSigma
Discover the complete record of transactions filed by Jeffrey Borcherding, Chairman & CEO. Director active across 2 companies, notably Immunovia AB (publ). Cumulatively, 1 filings have been logged. The latest transaction was filed on 22 May 2025 — Purchase. Regulator: FIN-FSA. The full history is free.
1 of 1 declaration
Jeffrey Borcherding is the CEO of Immunovia AB (publ). In this role, he oversees daily operations and the implementation of the company's strategy. His experience in the biotechnology sector is essential for Immunovia.